0.1405
-0.0044 (-3.04%)
-0.0044 (-3.04%)
Upgrade to Real-Time
Regular Market
| Volume | 237,719 |
|
|||||
| News | - | ||||||
| Day High | 0.152 | Low High |
|||||
| Day Low | 0.1405 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Eloxx Pharmaceuticals Inc | ELOX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.0044 | -3.04% | 0.1405 | 14:32:37 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.1474 | 0.1405 | 0.152 | 0.1449 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 250 | 237,719 | $ 0.1454487 | $ 34,576 | - | 0.1052 - 1.01 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 14:24:41 | 16 | $ 0.1476 | USD |
Period:
Draw Mode:
Eloxx Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 12.18M | 86.66M | 71.57M | $ - | $ - | -0.97 | -0.30 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | - | 23.20% |
Eloxx Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ELOX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.13 | 0.18 | 0.1255 | 0.144188 | 894,498 | 0.0105 | 8.08% |
| 1 Month | 0.1588 | 0.18 | 0.1052 | 0.138769 | 335,065 | -0.0183 | -11.52% |
| 3 Months | 0.3575 | 0.42 | 0.1052 | 0.1734692 | 230,231 | -0.217 | -60.7% |
| 6 Months | 0.281 | 0.48 | 0.1052 | 0.2431549 | 222,684 | -0.1405 | -50.0% |
| 1 Year | 0.71 | 1.01 | 0.1052 | 0.4704895 | 309,184 | -0.5695 | -80.21% |
| 3 Years | 5.07 | 8.1614 | 0.1052 | 1.72 | 423,588 | -4.93 | -97.23% |
| 5 Years | 10.35 | 24.60 | 0.1052 | 2.81 | 312,369 | -10.21 | -98.64% |
Eloxx Pharmaceuticals Description
| Eloxx Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing novel ribonucleic acid (RNA)-modulating drug candidates that are formulated to treat rare and ultra-rare premature stop codon diseases. The ELX-02, the company's lead investigational drug product candidate, is a small molecule designed to restore the production of full-length functional proteins. The ELX-02, is in the early stages of clinical development for systemic administration for cystic fibrosis and cystinosis. |